Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc.

NYSE:EBS

Overview | Financials
Company Name Emergent BioSolutions Inc.
Symbol EBS
Currency USD
Price 5.55
Market Cap 290,830,545
Dividend Yield 0%
52-week-range 1.42 - 9.96
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Richard S. Lindahl M.B.A.
Website https://www.emergentbiosolutions.com

An error occurred while fetching data.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and

Related Stocks

Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc.

MD

7.74 USD

Nevro Corp. logo

Nevro Corp.

NVRO

11.4 USD

U.S. Physical Therapy, Inc. logo

U.S. Physical Therapy, Inc.

USPH

106.72 USD

Glaukos Corporation logo

Glaukos Corporation

GKOS

109.79 USD

Warby Parker Inc. logo

Warby Parker Inc.

WRBY

16.53 USD

Taro Pharmaceutical Industries Ltd. logo

Taro Pharmaceutical Industries Ltd.

TARO

42.3 USD

Arcus Biosciences, Inc. logo

Arcus Biosciences, Inc.

RCUS

16.9 USD

Avanos Medical, Inc. logo

Avanos Medical, Inc.

AVNS

20.39 USD

Financials

Numbers are in millions USD

Numbers are in millions USD